Pier Capital’s Evolent Health EVH Stock Holding History

Pier Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-667,999	Closed	-$8.4M	–	111
2019 Q1	$8.4M	Buy	667,999 +332,820	+99%	+$5.27M	1.3%	14
2018 Q4	$6.69M	Buy	335,179 +6,661	+2%	+$154K	1.33%	10
2018 Q3	$9.33M	Sell	328,518 -123,034	-27%	-$2.93M	1.18%	16
2018 Q2	$9.51M	Buy	+451,552	New	+$8.55M	1.31%	6
2017 Q1	–	Sell	-313,669	Closed	-$4.64M	–	116
2016 Q4	$4.64M	Buy	313,669 +74,446	+31%	+$1.47M	0.84%	81
2016 Q3	$5.89M	Buy	+239,223	New	+$5.59M	1.04%	37
2016 Q2	–	Sell	-328,519	Closed	-$3.47M	–	121
2016 Q1	$3.47M	Sell	328,519 -37,905	-10%	-$392K	0.67%	87
2015 Q4	$4.44M	Sell	366,424 -8,716	-2%	-$128K	0.77%	77
2015 Q3	$5.99M	Sell	375,140 -5,214	-1%	-$102K	0.98%	63
2015 Q2	$7.42M	Buy	+380,354	New	+$7.09M	1.07%	21

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Pier Capital's EVH Position: Q2 2019 in Review

Pier Capital sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 667,999 shares — an estimated $8.4M sold.

Pier Capital first reported a position in EVH in Q2 2015 and held it in 10 quarters. The position peaked at $9.51M in Q2 2018. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Pier Capital reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Pier Capital sold 667,999 Evolent Health shares in Q2 2019, an estimated $8.4M.
Pier Capital first reported a position in Evolent Health in Q2 2015 and held it in 10 quarters.
Pier Capital's Evolent Health position peaked at $9.51M in Q2 2018.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Pier Capital's 13F filing for Q2 2019, filed 14 Aug 2019.